Lopez Ibor
Pediatric hematologist/oncologist
For Dr. Blanca López-Ibor, pediatric cancer patients must be treated from an integral point of view. This is what they do at HM CIOCC thanks to the equipment they have and the infrastructure they have. The facilities are essential to be able to carry out the care that pediatric patients require. For Dr. Blanca López-Ibor it is important that the pediatrician makes a good story and always listens to what the parents have to say. What is the survival rate for children from cancer diseases? In Spain, in neighboring countries, and in developed countries, childhood cancer survival today is around 80% of cases.
Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.
She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.
Certification & Accreditation
Location
The prestigious Dr. López-Ibor has a degree in Medicine from the Complutense University of Madrid and a doctorate from the University of Barcelona. Specialist in Pediatric Hematology and Oncology from the University of Maryland (United States), she is an expert in the treatment of bone and brain tumors, as well as in leukemia and hematological diseases.
With more than two decades of experience, he currently directs the Pediatric Hematology and Oncology Unit of the HM Montepríncipe Hospital, where children and adolescents are cared for. Previously, he held the same position at the Hospital Universitario Clínica San Rafael. In addition, she is the author of numerous national and international scientific publications.
How are we doing?